At first glance, an analysis of the 3,914 cases of CLL in UMD_TP53 shows a mutation profile similar to those of other cancers (Figures 3C, D), with 76% of missense mutations mostly localized in the DNA-binding domain of TP53. Here, TP53 is linked to B-cell chronic lymphocytic leukemia.